"Alerted.org

At Editas Medicine, we are pioneering the possible. Our mission is to translate the power and potential of CRISPR/Cas12a and CRISPR/Cas9 genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases.

Why Choose Editas?

At Editas Medicine, we’re a team of passionate problem solvers, harnessing the power and potential of CRISPR gene editing to transform the future of medicine. Driven by a shared purpose to serve people living with serious diseases, we succeed together through collaboration, mutual respect, and innovation. If you want to be part of a team where your voice is heard and respected and where you can operate at the forefront of gene editing, become an Editor!

This role is to help advance our lead in vivo development candidate, EDIT-401, a potential best-in-class, one-time therapy designed to significantly reduce LDL cholesterol levels. The company is very excited by the potential of this experimental treatment which has demonstrated the ability to reduce mean LDL cholesterol levels by over 90 percent in non-human primates. If you are a candidate excited to help push the boundaries of what’s possible in medicine, apply now.

Decoding The Role:

The Director, Project Management will lead the planning and execution of the cross-functional workstreams from pre-IND through to commercial launch. This role is responsible for leading cross functional partners in the development of a detailed program timeline in Smartsheet, clear functional budgets, and an aligned view of the program critical path. The Director, PM role will manage the weekly Program team meeting to ensure seamless cross-functional coordination of workstreams, to identify and mitigate program risks, and to successfully deliver to key program milestones (Pre-IND, IND, Phase I, II, and transition to registrational study). The ideal candidate will bring deep experience in clinical trial operations and project management within biotech or pharmaceutical settings, particularly in gene therapy programs.

This position will operate in a highly matrixed, fast-paced biotech environment from Editas’s Cambridge, MA headquarters. An ideal candidate demonstrates:

+ Strong communication skills: this candidate is able to effectively partner with internal and external stakeholders across the team. This candidate balances inquiry with advocacy when engaging with teammates to ensure he/she fully understands a situation before engaging in problem solving.

+ Organizational skills: this candidate is a detailed oriented planner, diligently confirming and aligning the functional plans of her / his peers. This candidate has a track record of establishing program structure; he / she enables a logical, process-driven approach to enhance collaboration across teams.

+ Teamwork and leadership: This candidate possesses a highly collaborative mindset and is skilled at productive debate that builds team commitment to a recommended path forward. This candidate tests functional thinking and respectfully challenges his/her teammates to get to reasonable program assumptions.

+ Adaptability: This candidate has demonstrated the ability to balance multiple priorities and adapt their approach to be successful in a fast paced, dynamic biotech environment.

Characterizing Your Impact:

As the Director, Program Management , you will:

+ Lead the operational planning and execution of the cross-functional program plan; establish and reinforce a Program structure that enables cross-functional collaboration

+ Develop detailed project plans including timelines, milestones, interdependencies, budgets, and the Program Team critical path

+ Coordinate activities and deliverables across functional teams including Clinical, Non-clinical, Regulatory, CMC, and Data Management.

+ Track progress against plans, identify risks, and implement mitigation strategies.

+ Provide regular updates to leadership and governance committees.

Requirements

The Ideal Transcript:

To thrive in this role, you’ll need:

+ A minimum of a bachelor’s degree in life sciences or related subjects; advanced degrees (MBA) are desirable.

+ 8-10 years of experience in biotech/pharma, with 3-5 years in program management supporting early-stage clinical development. Experience managing multiple programs at the same time is desirable.

+ Proven track record of leading cross-functional teams in a matrixed environment.

+ Strong understanding of preclinical development, IND-enabling studies, and early clinical trial operations. Experience across functional roles is desirable.

+ Experience with gene therapy or gene therapy programs is highly desirable.

+ Mastery of project management tools and methodologies, including Smartsheet, Microsoft Project, and OnePager

Benefits

Editas provides a comprehensive array of benefits to all employees, including a Blue Cross Blue Shield PPO Medical Plan, a company-funded Health Savings Account, Dental and Vision Insurance, Life and Disability Insurance, Dependent Care Account, Tuition Reimbursement, 401(k) plan with company match, Employee Stock Purchase Plan, Employee Assistance Plan, Wellness Programs, and a flexible Paid Time Off policy.

Salary Range:

$210,000 - $230,000

Pay Transparency

Editas Medicine is committed to transparency and accuracy in our hiring practices. The anticipated salary range for each position is posted within the role. The final salary offer will be determined based on a comprehensive assessment of the candidate's qualifications, including education, training, and relevant experience. Additional factors such as external market conditions, the role's criticality, and internal equity will also be considered. Editas Medicine's compensation philosophy ensures fair and equitable pay practices.

Aspire to be an Editor?

We invite you to apply and join us at the forefront of innovation and be a key contributor to realizing Editas Medicine's mission of developing transformative medicines for people living with serious diseases.